Molecular mechanisms of glucocorticoid action: What is important?

Thorax

Volumn 55, Issue 7, 2000, Pages 603-613

  Newton, Robert ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GROWTH FACTOR;

APOPTOSIS; ASTHMA; DNA BINDING; EOSINOPHIL; GENETIC TRANSCRIPTION; HUMAN; PRIORITY JOURNAL; REVIEW;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; ASTHMA; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSION; MICE; RECEPTORS, GLUCOCORTICOID; STEROIDS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 0034130914     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.7.603     Document Type: Review

References (142)

1. 1 Burnus PJ. Pathophysiology of asthma. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma: Basic mechanisms and clinical management. London: Academic Prress, 1998: 487-506.
2. 2 Barnes PJ. Glucocorticosteroids. In: Barnes PJ, Rodger TW, Thomson NC, eds. Asthma: Basic mechanisms and clinical management. London: Academic Press, 1998: 725-66.
3. 3 Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999;402(Suppl):B31-8.
4. 4 Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213-339.
5. 5 King KL, Cidlowski JA. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998;60:601-17.
6. 6 Lanza L, Scudeletti M, Puppo F, et al. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol 1996;103:482-90.
7. 7 Northrop JP, Crabtree GR, Mattila PS. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J Exp Med 1992;175:1235-45.
8. 8 Guizani L, Perrin WM, Breard J, et al. Mechanisms in interleukin-2 protection against glucocorticoid-induced apoptosis: regulation of AP-1 and glucocorticoid receptor transcriptional activities. J Interferon Cytokine Res 1996;16: 601-9.
9. 9 Schmidt M, Pauels HG, Lugering N, et al. Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta. J Immunol 1999;163:3484-90.
10. 10 Jantzen HM, Strahle U, Gloss B, et al. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 1987;49:29-38.
11. 11 Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 1997;66:581-611.
12. 12 Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell 1998;93:487-90.
13. 13 Reichardt HM, Schutz G. Glucocorticoid signalling: multiple variations of a common theme. Mol Cell Endocrinol 1998;146:1-6.
14. 14 Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
15. 15 Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318:635-41.
16. 16 Giguere V, Hollenberg SM, Rosenfeld MG, et al. Functional domains of the human glucocorticoid receptor. Cell 1986;46:645-52.
17. 17 Hollenberg SM, Evans RM. Multiple and cooperative transactivation domains of the human glucocorticoid receptor. Cell 1988;55:899-906.
18. 18 Dahlman-Wright K, Baumann H, McEwan IJ, et al. Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc Natl Acad Sci USA 1995;92:1699-703.
19. 19 Beato M, Truss M, Chavez S. Control of transcription by steroid hormones. Ann NY Acad Sci 1996;784:93-123.
20. 20 Bamberger CM, Bamberger AM, de Castro M, et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995;95: 2435-41.
21. 21 Oakley RH, Jewell CM, Yudt MR, et al. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J Biol Chem 1999;274:27857-66.
22. 22 Beato M. Gene regulation by steroid hormones. Cell 1989;56:335-44.
23. 23 Strahle U, Klock G, Schutz G. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc Natl Acad Sci USA 1987;84:7871-5.
24. 24 Karin M, Haslinger A, Holtgreve H, et al. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 1984;308:513-9.
25. 25 Webster MK, Goya L, Ge Y, et al. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. J Biol Chem 1993;13:2031-40.
26. 26 Renkawitz R, Schutz G, von-der-Ahe D, et al. Sequences in the promoter region of the chicken lysozyme gene required for steroid regulation and receptor binding. Cell 1984;37: 503-10.
27. 27 Stromstedt PE, Poellinger L, Gustafsson JA, et al. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. J Biol Chem 1991;11: 3379-83.
28. 28 Dahlman WK, Wright A, Gustafsson JA, et al. Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 1991;266:3107-12.
29. 29 Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994;15:71-6.
30. 30 Yao XL, Cowan MJ, Gladwin MT, et al. Dexamethasone alters arachidonate release from human epithelial cells by induction of p11 protein synthesis and inhibition of phospholipase A2 activity. J Biol Chem 1999;274:17202-8.
31. 31 Collins S, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988;263:9067-70.
32. 32 Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol 1995;268:L41-6.
33. 33 Abbinante NJ, Simpson LG, Leikauf GD. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1995;268: L601-6.
34. 34 Colotta F, Re F, Muzio M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993;261:472-5.
35. 35 Taylor IK, Shaw RJ. The mechanism of action of corticosteroids in asthma. Respir Med 1993;87:261-77.
36. 36 Cato AC, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996;18: 371-8.
37. 37 Charron J, Drouin J. Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter. Proc Natl Acad Sci USA 1986;83:8903-7.
38. 38 Drouin J, Sun YL, Chamberland M, et al. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. EMBO J 1993;12:145-56.
39. 39 Riegel AT, Lu Y, Remenick J, et al. Proopiomelanocortin gene promoter elements required for constitutive and glucocorticoid-repressed transcription. Mol Endocrinol 1991;5:1973-82.
40. 40 Murphy EP, Conneely OM. Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1 nur77 subfamily of nuclear receptors. Mol Endocrinol 1997;11:39-47.
41. 41 Philips A, Maira M, Mullick A, et al. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. J Biol Chem 1997;17:5952-9.
42. 42 Akerblom IE, Slater EP, Beato M, et al. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 1988;241:350-3.
43. 43 Meyer T, Gustafsson JA, Carlstedt DJ. Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol 1997;16:919-27.
44. 44 Newton R, Barnes PJ, Adcock IM. Transcription factors. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma: Basic mechanisms and clinical management. London: Academic Press, 1998: 459-474.
45. 45 Sakai DD, Helms S, Carlstedt DJ, et al. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev 1988;2:1144-54.
46. 46 Schule R, Rangarajan P, Kliewer S, et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990;62:1217-26.
47. 47 Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990;62: 1189-204.
48. 48 Yang Yen HF, Chambard JC, Sun YL, et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;62:1205-15.
49. 49 Konig H, Ponta H, Rahmsdorf HJ, et al. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 1992;11:2241-6.
50. 50 Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994;91:752-6.
51. 51 Scheinman RI, Gualberto A, Jewell CM, et al. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. J Biol Chem 1995;15:943-53.
52. 52 Mukaida N, Morita M, Ishikawa Y, et al. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994;269:13289-95.
53. 53 Scheinman RI, Cogswell PC, Lofquist AK, et al. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270: 283-6.
54. 54 Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 1995;270: 286-90.
55. 55 Newton R, Hart LA, Stevens DA, et al. Effect of dexamethasone on interleukin-1beta (IL-1beta) induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells. Eur J Biochem 1998;254:81-9.
56. 56 Le Bail O, Schmidt Ullrich R, Israel A. Promoter analysis of the gene encoding the I kappa B-alpha MAD 3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J 1993;12:5043-9.
57. 57 Vanden Berghe W, Francesconi E, De Bosscher K, et al. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Mol Pharmacol 1999;56: 797-806.
58. 58 Brostjan C, Anrather J, Csizmadia V, et al. Glucocorticoids inhibit E-selectin expression by targeting NF-kappaB and not ATF/c-Jun. J Immunol 1997;158:3836-44.
59. 59 Brostjan C, Anrather J, Csizmadia V, et al. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of I kappa B alpha synthesis. J Biol Chem 1996;271:19612-6.
60. 60 Ray KP, Farrow S, Daly M, et al. Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem J 1997;328:707-15.
61. 61 Ohtsuka T, Kubota A, Hirano T, et al. Glucocorticoid-mediated gene suppression of rat cytokine-induced neutrophil chemoattractant CINC/gro, a member of the interleukin-8 family, through impairment of NF-kappa B activation. J Biol Chem 1996;271:1651-9.
62. 62 Heck S, Bender K, Kullman M, et al. IkBu-independent downregulation of NF-kB activity by glucocorticoid receptor. EMBO J 1997;16:4698-707.
63. 63 De-Bosscher K, Schmitz ML, Vanden-Berghe W, et al. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 1997;94: 13504-9.
64. 64 Heck S, Kullmann M, Gast A, et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 1994;13:4087-95.
65. 65 Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85:403-14.
66. 66 Sheppard KA, Phelps KM, Williams AJ, et al. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 1998;273:29291-4.
67. 67 Kwok RP, Lundblad JR, Chrivia JC, et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994;370:223-6.
68. 68 Swope DL, Mueller CL, Chrivia JC. CREB-binding protein activates transcription through multiple domains. J Biol Chem 1996;271:28138-45.
69. 69 Chakravarti D, LaMorte VJ, Nelson MC, et al. Role of CBP/P300 in nuclear receptor signalling. Nature 1996;383: 99-103.
70. 70 Gerritsen ME, Williams AJ, Neish AS, et al. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 1997;94:2927-32.
71. 71 Shikama N, Lyon J, La Thange NB. The p300/CBP family: Integrating signals with transcription factors and chromatin. Trends Cell Biol 1997;7:230-6.
72. 72 Bannister AJ, Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature 1996;384:641-3.
73. 73 Ogryzko VV, Schiltz RL, Russanova V, et al. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 1996;87:953-9.
74. 74 Yang XJ, Ogryzko VV, Nishikawa J, et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996;382:319-24.
75. 75 Chen H, Lin RJ, Schiltz, RL, et al. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/ p300. Cell 1997;90:569-80.
76. 76 Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 1998;12:599-606.
77. 77 Tsai CC, Kao HY, Yao TP, et al. SMRTER, a Drosophila nuclear receptor coregulator, reveals that EcR-mediated repression is critical for development. Mol Cell 1999;4:175-86.
78. 78 Liden J, Delaunay F, Rafter I, et al. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 1997;272: 21467-72.
79. 79 Vayssiere BM, Dupont S, Choquart A, et al. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 1997;11:1245-55.
80. 80 Meyer T, Carlstedt DJ, Starr DB. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 1997;272:30709-14.
81. 81 Hauschka PV, Lian JB, Cole DE, et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047.
82. 82 Belvisi MG, Wicks S, Battram C, et al. Does the synthetic glucocorticoid, RU 24858, which dissociates transactivation and transrepression in vitro possess anti-inflammatory properties without steroid adverse side effects in vivo? Am J Respir Crit Care Med 1999;153:A108.
83. 83 Cole TJ, Blendy JA, Monaghan AP, et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-21.
84. 81 Kretz O, Reichardt HM, Schutz G, et al. Corticotropin-releasing hormone expression is the major target for glucocorticoid feedback-control at the hypothalamic level. Brain Res 1999;818:488-91.
85. 85 Reichardt HM, Kaestner KH, Tuckermann J, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998;93:531-41.
86. 86 Jacobson A, Peltz, SW. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem 1996;65:693-739.
87. 87 Kleijn M, Scheper GC, Voorma HO, et al. Regulation of translation initiation factors by signal transduction. Eur J Biochem 1998;253:531-44.
88. 88 Rhoads RE. Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 1999;274:30337-40.
89. 89 Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67.
90. 90 Huarte J, Stutz, A, O'Connell ML, et al. Transient translational silencing by reversible mRNA deadenylation. Cell 1992;69:1021-30.
91. 91 Kruys V, Marinx O, Shaw G, et al. Translational blockade imposed by cytokine-derived UA-rich sequences. Science 1989;245:852-5.
92. 92 Rajagopalan LE, Malter JS. Modulation of granulocyte-macrophage colony-stimulating factor mRNA stability in vitro by the adenosine-uridine binding factor. J Biol Chem 1994;269:23882-8.
93. 93 Rajagopalan LE, Burkholder JK, Turner J, et al. Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues. Blood 1995;86:2551-8.
94. 94 Caput D, Beutler B, Hartog K, et al. Identification of a common nucleotide sequence in the 3′ untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986;83:1670-4.
95. 95 Yang L, Yang YC. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J Biol Chem 1994;269:32732-9.
96. 96 Kern JA, Warnock LJ, McCafferty JD. The 3′ untranslated region of IL-1beta regulates protein production. J Immunol 1997;158:1187-93.
97. 97 Henics T, Sanfridson A, Hamilton BJ, et al. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J Biol Chem 1994;269:5377-83.
98. 98 Chen CY, Del Gatto Konczak F, Wu Z, et al. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998;280:1945-9.
99. 99 Winzen R, Kracht M, Ritter B, et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 1999;18:4969-80.
100. 100 Ristimaki A, Garfinkel S, Wessendorf J, et al. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation. J Biol Chem 1994;269: 11769-75.
101. 101 Newton R, Seybold S, Liu SF, et al. Alternate COX-2 transcripts are differentially regulated: implications for post-transcriptional control. Biochem Biophys Res Commun 1997;234:85-9.
102. 102 Barrios RM, Tiraloche G, Chadee K. Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and post-transcriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha. J Immunol 1999;163:963-9.
103. 103 Mitchell JA, Belvisi MG, Akarasereenont P, et al. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994;113:1008-14.
104. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 1997;60:67-78.
105. 105 Newton R, Kuitert LM, Bergmann M, et al. Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β, Biochem Biophys Res Commun 1997;237:28-32.
106. 2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J Biol Chem 1998;273:32312-21.
107. 107 Krane IM, Spindel ER, Chin WW. Thyroid hormone decreases the stability and the poly(A) tract length of rat thyrotropin beta-subunit messenger RNA. Mol Endocrinol 1991;5:469-75.
108. 108 Crawford EK, Ensor JE, Kalvakolanu I, et al. The role of 3′ poly(A) tail metabolism in tumor necrosis factor-alpha regulation. J Biol Chem 1997;272:21120-7.
109. 109 Ristimaki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 1996;318:325-31.
110. 110 Lee SW, Tsou AP, Chan H, et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci USA 1988;85:1204-8.
111. 111 Kern JA, Lamb RJ, Reed JC, a al. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 1988;81: 237-44.
112. 112 Tobler A, Meier R, Seitz M, et al. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 1992;79:45-51.
113. 113 Knudsen PJ, Dinarello CA, Strom TB. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 1987;139:4129-34.
114. 114 Peppel K, Vinci JM, Baglioni C. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 1991;173:349-55.
115. 115 Walker G, Pfeilschifter J, Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in posttranscriptional regulation. J Biol Chem 1997;272:16679-87.
116. 116 Swantek JL, Cobb MH, Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/ SAPK. J Biol Chem 1997;17:6274-82.
117. 117 Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990;171:465-75; 971-2 (erratum).
118. 118 Han J, Huez G, Beutler B. Interactive effects of the tumor necrosis factor promoter and 3′ untranslated regions. J Immunol 1991;146:1843-8.
119. 119 Gueydan C, Droogmans L, Chalon P, et al. Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. J Biol Chem 1999;274:2322-6.
120. 120 Huang S, Hershey JW. Translational initiation factor expression and ribosomal protein gene expression are repressed coordinately but by different mechanisms in murine lymphosarcoma cells treated with glucocorticoids. J Biol Chem 1989;9:3679-84.
121. 121 Newton R, Staples KJ, Nasuhara Y, et al. Inhibition of GM-CSF synthesis by glucocorticoids does not involve down-regulation of promoter activity in primary human T-cells. Am J Respir Crit Care Med 1999;159:A754.
122. 122 Poon M, Liu B, Taubman MB. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA. J Biol Chem 1999;19:6471-8.
123. 123 Cidlowski JA, King KL, Evans SR, et al. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent Prog Horm Res 1996;51:457-90.
124. 124 Nieto MA, Gonzalez A, Gambon F, et al. Apoptosis in human thymocytes after treatment with glucocorticoids. Clin Exp Immunol 1992;88:341-4.
125. 125 Wyllie AH, Morris RG, Smith AL, et al. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67-77.
126. 126 Ramdas J, Hasday JD. Glucocorticoid-induced apoptosis and regulation of NF-kappaB activity in human leukemic T cells. Endocrinology 1998;139:3813-21.
127. 127 Reisman D, Thompson EA. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells. Mol Endocrinol 1995;9:1500-9.
128. 128 Diamond MI, Miner JN, Yoshinaga SK, et al. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990;249: 1266-72.
129. 129 Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 1993;259: 1161-5.
130. 130 Pearce D, Matsui W, Miner JN, et al. Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J Biol Chem 1998;273:30081-5.
131. 131 Schule R, Muller M, Otsuka Murakami H, et al. Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature 1988;332:87-90.
132. 132 Strahle U, Schmid W, Schutz G. Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J 1988;7:3389-95.
133. 133 Schule R, Muller M, Kakschmidt C, et al. Many transcription factors interact synergistically with steroid receptors. Science 1988;242:1418-20.
134. 134 Gotoh T, Chowdhury S, Takiguchi M, et al. The glucocorticoid-responsive gene cascade. Activation of the rat arginase gene through induction of C EBPbeta. J Biol Chem 1997;272:3694-8.
135. 135 Imai E, Miner JN, Mitchell JA, et al. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993;268: 5353-6.
136. 136 Kordula T, Travis J. The role of Stat and C EBP transcription factors in the synergistic activation of rat serine protease inhibitor-3 gene by interleukin-6 and dexamethasone. Biochem J 1996;313:1019-27.
137. 137 Stocklin E, Wissler M, Gouilleux F, et al. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1997;383:726-8.
138. 138 Cella N, Groner B, Hynes NE. Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocortiocoid receptor in mammary cells. J Biol Chem 1998;18:1783-92.
139. 139 Klauck TM, Xu X, Mousseau B, et al. Cloning and characterization of a glucocorticoid-induced diacylglycerol kinase. J Biol Chem 1996;271:19781-8.
140. 140 Kemppainen RJ, Behrend EN. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J Biol Chem 1998;273:3129-31.
141. 141 Dunham I, Shimizu N, Roe BA, et al. The DNA sequence of human chromosome 22. Nature 1999;402:489-95.
142. 142 Cheung VG, Morley M, Aguilar F, et al. Making and reading microarrays. Nature Genetics 1999;21:15-9.